Marketed formulations of extended phenytoin sodium -- long a difficult medication to titrate because of its unique absorption and saturable elimination pharmacokinetics -- may not be bioequivalent ...

This study showed that intravenous sodium valproate has non-inferior efficacy to intravenous phenytoin as the first-line treatment of SE. The intravenous sodium valproate group had better outcomes ...